Frances Hull

NPI: 1336531870
Total Payments
$4,164
2024 Payments
$1,421
Companies
34
Transactions
207
Medicare Patients
512
Medicare Billing
$26,174

Payment Breakdown by Category

Food & Beverage$4,164 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,164 207 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $839.52 26 $0 (2024)
ABBVIE INC. $681.99 52 $0 (2024)
GlaxoSmithKline, LLC. $343.50 13 $0 (2024)
PFIZER INC. $340.66 23 $0 (2024)
Otsuka America Pharmaceutical, Inc. $269.17 4 $0 (2024)
Novo Nordisk Inc $251.86 23 $0 (2024)
Xeris Pharmaceuticals, Inc. $177.13 9 $0 (2024)
Astellas Pharma US Inc $171.48 7 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $118.13 4 $0 (2024)
Sunovion Pharmaceuticals Inc. $110.47 5 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,421 77 ABBVIE INC. ($224.08)
2023 $1,556 88 AstraZeneca Pharmaceuticals LP ($382.20)
2022 $930.76 38 AstraZeneca Pharmaceuticals LP ($247.29)
2021 $256.92 4 Otsuka America Pharmaceutical, Inc. ($115.69)

All Payment Transactions

207 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/20/2024 Chiesi USA, Inc. MYCAPSSA (Drug) Food and Beverage Cash or cash equivalent $19.59 General
Category: ACROMEGALY
12/18/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.11 General
Category: Diabetes
12/12/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $12.62 General
Category: PAIN
12/05/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $6.16 General
Category: NEUROSCIENCE
11/21/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $15.00 General
Category: PSYCHIATRY
11/20/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.61 General
Category: Diabetes
11/20/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.04 General
Category: NEUROSCIENCE
11/12/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $21.05 General
Category: PAIN
11/11/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $19.30 General
Category: RESPIRATORY
11/07/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $7.50 General
Category: NEUROSCIENCE
11/06/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $27.10 General
Category: DIABETES
10/17/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $17.14 General
Category: NEUROSCIENCE
10/17/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $10.17 General
Category: NEUROSCIENCE
10/10/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $13.55 General
Category: HIV
10/08/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $8.86 General
Category: NEUROSCIENCE
10/04/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $36.21 General
Category: INTERNAL MEDICINE
10/03/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $15.20 General
09/27/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $22.95 General
09/25/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $21.76 General
Category: Biological
09/25/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $13.42 General
Category: PSYCHIATRY
09/18/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $32.19 General
Category: HIV
09/12/2024 Alnylam Pharmaceuticals Inc. OXLUMO (Drug) Food and Beverage In-kind items and services $22.36 General
Category: Genetic Disease
09/11/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Food and Beverage In-kind items and services $23.01 General
Category: Endocrine & Metabolic Diseases
08/27/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.00 General
Category: Diabetes
08/22/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $24.92 General
Category: Biological

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 2 73 73 $16,206 $4,736
2021 5 245 257 $39,470 $13,628
2020 4 194 217 $26,624 $7,810
Total Patients
512
Total Services
547
Medicare Billing
$26,174
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 43 43 $10,836 $3,205 29.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 30 30 $5,370 $1,531 28.5%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 47 48 $12,096 $4,670 38.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 63 65 $11,497 $4,048 35.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 78 87 $10,062 $3,087 30.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 13 13 $3,219 $1,110 34.5%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 44 44 $2,596 $713.04 27.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 80 97 $11,349 $3,426 30.2%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 33 35 $8,820 $2,584 29.3%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 69 73 $4,307 $1,179 27.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 12 12 $2,148 $620.88 28.9%

About Frances Hull

Frances Hull is a Registered Nurse healthcare provider based in Yakima, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1336531870.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Frances Hull has received a total of $4,164 in payments from pharmaceutical and medical device companies, with $1,421 received in 2024. These payments were reported across 207 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,164).

As a Medicare-enrolled provider, Hull has provided services to 512 Medicare beneficiaries, totaling 547 services with total Medicare billing of $26,174. Data is available for 3 years (2020–2022), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Registered Nurse
  • Other Specialties Family
  • Location Yakima, WA
  • Active Since 02/20/2015
  • Last Updated 01/17/2020
  • Taxonomy Code 163W00000X
  • Entity Type Individual
  • NPI Number 1336531870

Products in Payments

  • FARXIGA (Drug) $488.38
  • REXULTI (Drug) $338.14
  • QULIPTA (Drug) $284.31
  • NURTEC ODT (Drug) $283.47
  • UBRELVY (Drug) $222.46
  • SHINGRIX (Biological) $176.57
  • Veozah (Drug) $171.48
  • GEMTESA (Drug) $169.38
  • GVOKE HYPOPEN (Drug) $159.95
  • TRELEGY ELLIPTA (Drug) $142.22
  • Ozempic (Drug) $135.10
  • VRAYLAR (Drug) $131.50
  • Rybelsus (Drug) $109.90
  • INGREZZA (Drug) $102.85
  • JARDIANCE (Drug) $88.39
  • SOLIQUA 100/33 (Biological) $57.77
  • PAXLOVID (Drug) $57.19
  • APRETUDE (Biological) $45.74
  • LEQVIO (Drug) $37.63
  • ENTYVIO (Biological) $36.21

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Registered Nurse Doctors in Yakima